Wolfgang Stremmel
Has participated in:
-
Phospholipase A 2 of Microbiota as Pathogenetic Determinant to Induce Inflammatory States in Ulcerative Colitis: Therapeutic Implications of Phospholipase A 2 Inhibitors
-
Bis(monoacylglycerin)phosphat: ein "Marker"-Phosphatid sekundärer Lysosomen
-
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
-
Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene showfeatures of lethal restrictive dermopathy